Navidea Biopharmaceuticals, Inc.(NAVB)

Description: Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. The company's radiopharmaceutical development programs include Lymphoseek Injection, a receptor-targeted small-molecule investigational radiopharmaceutical that is used in lymphatic mapping procedures, which are performed to help stage breast cancer and melanoma; and NAV4694, an F-18 radiolabeled positron emission tomography imaging agent, which is used as an aid in the diagnosis of patients with signs or symptoms of cognitive impairment, such as Alzheimer's disease. Its radiopharmaceutical development programs also comprise NAV5001, an Iodine-123 radiolabeled single photon emission computed tomography imaging agent that is used as an aid in the diagnosis of Parkinson's disease and other movement disorders with potential use as a diagnostic aid in dementia; and RIGScan, a radiolabeled monoclonal antibody that is developed as a diagnostic aid for use during surgery to help surgeons locate occult or metastatic cancer, primarily colorectal cancer. It has research and development agreements with University of California, AstraZeneca AB, Alseres Pharmaceuticals, Inc., and The Ohio State University. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was founded in 1983 and is headquartered in Dublin, Ohio.

---

Keywords: Medicine Biopharmaceutical Surgery Breast Cancer Alzheimer's Disease Parkinson's Disease Monoclonal Antibody Medical Physics Melanoma Colorectal Cancer Dementia Tomography Nuclear Medicine Radiopharmaceuticals Movement Disorders Positron Emission Tomography Medicinal Radiochemistry Metastasis Iodine Metastatic Cancer Cognitive Impairment Neuroimaging Imaging Agent Ohio State University Radiochemistry Single Photon Emission Computed Tomography The Ohio State University

---

Home Page: www.navidea.com

NAVB Technical Analysis

4995 Bradenton Avenue
Dublin, OH 43017-3552
United States
Phone: 614 793 7500

---

Officers

Exchange: NYSE MKT

Country: US

Currency: US Dollar ($)